Mar 3, 2026 08:00AM

Feb 2, 2026 09:27AM

Jan 14, 2026 08:00AM

Jan 2, 2026 08:00AM

Dec 2, 2025 09:53AM

Nov 17, 2025 08:00AM

Oct 17, 2025 08:26AM PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale

Oct 16, 2025 08:04AM

Oct 16, 2025 08:00AM

Oct 15, 2025 08:00AM

Oct 8, 2025 08:00AM

Aug 27, 2025 08:00AM

Aug 14, 2025 08:02AM

Aug 14, 2025 08:00AM PharmaTher Founder and CEO Issues Letter to Shareholders Following the FDA Approval of Ketamine (KETARx(TM))

Aug 11, 2025 09:51AM

Aug 11, 2025 09:49AM

Mar 3, 2025 08:00AM

Oct 31, 2024 08:58AM

Sep 19, 2024 08:00AM

Aug 28, 2024 08:00AM

Aug 21, 2024 09:52AM PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

Aug 19, 2024 08:00AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All